Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As markets swing, a dominant growth stock may pull back while fundamentals stay strong. This guide explains how to sp...
Investors noticed a notable move in Ross Stores shares as the off-price retailer reported stronger results and a heal...
A distinct slice of the workforce born between 1993 and 1998 is leveraging tech fluency and disciplined money habits ...
A bitcoin miners ETF posted a dramatic weekly surge, underscoring how mining infrastructure can deliver cash flows ev...
A Windows malware strain is redirecting copied wallet addresses to attackers, prompting urgent advice to spot crypto ...
Brookfield is quietly expanding its private debt platform, aiming to become a major player in private credit. This ar...
A relatively small stock move can reveal big shifts in the lodging REIT world. See why an $8 million sale of Park Hot...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
A non-spouse beneficiary can dramatically lower or raise lifetime taxes on an inherited IRA depending on withdrawal t...
A high-profile murder case can rewrite the map of your finances. This article uses the Alex Murdaugh case to show pra...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...